PURPOSE: Recent preclinical and clinical studies show that dyes that excite and fluoresce in the near-infrared range may be used for tracking and detecting disease targets in vivo. A method for quantifying free dye molecules in antibody conjugate preparations is required for agent batch release and for translation into the clinic. PROCEDURES: Herein, we developed and validated a SDS-PAGE method to determine the percentage of free IRDye 800 CW in (DTPA)(n)-trastuzumab-(IRDye 800)(m) conjugate sample preparations in which high-performance liquid chromatography (HPLC) assessment of free dye was not possible. RESULTS: The SDS-PAGE assay was accurate and valid for free IRDye 800 CW amounts between 38 and 4 mol% of total dye. Gel sample preparation reagent affected the specificity of the assay, and lower and upper limits of quantitation and detection were determined. CONCLUSION: This method may be applicable to other near-infrared dye-conjugated antibody-based imaging agents in which HPLC assessment of purity is not feasible. This validated method for quality assurance will facilitate the translation of dual-labeled antibody conjugates for nuclear and optical imaging.
PURPOSE: Recent preclinical and clinical studies show that dyes that excite and fluoresce in the near-infrared range may be used for tracking and detecting disease targets in vivo. A method for quantifying free dye molecules in antibody conjugate preparations is required for agent batch release and for translation into the clinic. PROCEDURES: Herein, we developed and validated a SDS-PAGE method to determine the percentage of free IRDye 800 CW in (DTPA)(n)-trastuzumab-(IRDye 800)(m) conjugate sample preparations in which high-performance liquid chromatography (HPLC) assessment of free dye was not possible. RESULTS: The SDS-PAGE assay was accurate and valid for free IRDye 800 CW amounts between 38 and 4 mol% of total dye. Gel sample preparation reagent affected the specificity of the assay, and lower and upper limits of quantitation and detection were determined. CONCLUSION: This method may be applicable to other near-infrared dye-conjugated antibody-based imaging agents in which HPLC assessment of purity is not feasible. This validated method for quality assurance will facilitate the translation of dual-labeled antibody conjugates for nuclear and optical imaging.
Authors: R Simon; A Nocito; T Hübscher; C Bucher; J Torhorst; P Schraml; L Bubendorf; M M Mihatsch; H Moch; K Wilber; A Schötzau; J Kononen; G Sauter Journal: J Natl Cancer Inst Date: 2001-08-01 Impact factor: 13.506
Authors: B L Engelstad; L E Spitler; M J Del Rio; E C Ramos; L L Rosendorf; C E Reinhold; A Khentigan; J P Huberty; S W Corpuz; H M Lee Journal: Radiology Date: 1986-11 Impact factor: 11.105
Authors: A M Keenan; J N Weinstein; J L Mulshine; J A Carrasquillo; P A Bunn; J C Reynolds; S M Larson Journal: J Nucl Med Date: 1987-01 Impact factor: 10.057
Authors: Lakshmi Sampath; Sunkuk Kwon; Shi Ke; Wei Wang; Rachel Schiff; Michel E Mawad; Eva M Sevick-Muraca Journal: J Nucl Med Date: 2007-09 Impact factor: 10.057
Authors: Bindi Dhesy-Thind; Kathleen I Pritchard; Hans Messersmith; Frances O'Malley; Leela Elavathil; Maureen Trudeau Journal: Breast Cancer Res Treat Date: 2007-07-17 Impact factor: 4.872
Authors: Jacqueline Pei; Georgina Juniper; Nynke S van den Berg; Naoki Nisho; Trevor Broadt; Anthony R Welch; Grace S Yi; Roan C Raymundo; Stefania U Chirita; Guolan Lu; Giri Krishnan; Yu-Jin Lee; Shrey Kapoor; Quan Zhou; A Dimitrios Colevas; Natalie S Lui; George A Poultsides; Gordon Li; Kurt R Zinn; Eben L Rosenthal Journal: Mol Imaging Biol Date: 2020-09-03 Impact factor: 3.484
Authors: Melissa B Aldrich; Milton V Marshall; Eva M Sevick-Muraca; Greg Lanza; John Kotyk; Joseph Culver; Lihong V Wang; Jashim Uddin; Brenda C Crews; Lawrence J Marnett; Joseph C Liao; Chris Contag; James M Crawford; Ken Wang; Bill Reisdorph; Henry Appelman; D Kim Turgeon; Charles Meyer; Tom Wang Journal: Biomed Opt Express Date: 2012-03-22 Impact factor: 3.732